Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Healthcare Market Research Reports

Titlepublishedprice

Angola Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......or vaccines remain high. However, the country's pharmaceutical and healthcare market is greatly affected by its difficult operating environment, with corruption and poor infrastructure posing considerable challenges to foreign drugmakers operating in......"
27-Aug-2014$1295

Argentina Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......r local operations, if the hostile business environment is worsened. Headline Expenditure Projections Pharmaceuticals: ARS39.30bn (USD7.18 bn) in 2013 to ARS50.10bn (USD6.04bn) in 2014; +27.5% in local currency terms and -15.9% in US dollar terms. Th......"
27-Aug-2014$1295

Colombia Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......latively advanced drug reimbursement system will still offer revenue-generating opportunities for multinationals in comparison with other second-tier Latin American pharmaceutical markets. Headline Expenditure Projections ? Pharmaceuticals: COP8,126b......"
27-Aug-2014$1295

Hong Kong Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"...... ? Pharmaceuticals: HKD11.24bn (USD1.45bn) in 2013 to HKD12.12bn (USD1.56bn) in 2014; +7.8% in local currency terms and US dollar terms. Forecast broadly in line with Q314. ? Healthcare: HKD122.00bn (USD15.73bn) in 2013 to HKD130.97bn (USD16.85bn) in......"
27-Aug-2014$1295

Japan Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ing to the Central Social Insurance Medical Committee, the 2014 pharmaceutical price revision means that there will be, on average, a 5.7% reduction in pharmaceutical prices, excluding the effect of consumption tax. Drug prices were cut by an average......"
27-Aug-2014$1295

Mozambique Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......mmunisation, to help combat the county's high burden of disease. However, Mozambique's pharmaceutical market suffers from an abundance of counterfeit medicines in circulation partly. It's high dependence on costly imported drugs combined with a poor ......"
27-Aug-2014$1295

Namibia Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......er, we believe that healthcare access for many of the country's citizens is likely to remain problematic as long as the country's dependence on imports remains so high. Headline Expenditure Forecasts ? Pharmaceuticals: NAD2.47bn (USD256mn) in 2013 to......"
27-Aug-2014$1295

Netherlands Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ial medicines. Although healthcare expenditure continues to increase (in local currency terms), we maintain our view that additional caps on medicines prices will work to create a subdued outlook for patented and generic drugmakers operating in the c......"
27-Aug-2014$1295

South Korea Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......eadline Expenditure Projections ? Pharmaceuticals: KRW16,106.7bn (USD14.71bn) in 2013 to KRW16,590.4bn (USD15.80bn) in 2014; +3.0% in local currency terms and +7.4% in US dollar terms. Forecast broadly in line with Q314. ? Healthcare: KRW101,399.1bn ......"
27-Aug-2014$1295

Uganda Pharmaceuticals and Healthcare Report Q4 2014

By Business Monitor International
"......ability to provide adequate healthcare. Uganda also faces the threat of an Ebola outbreak spreading from neighbouring countries which are in the grip of an epidemic. Headline Expenditure Projections ? Pharmaceuticals: UGX824.35bn (USD320mn) in 2013 t......"
27-Aug-2014$1295
Live Chat
Live Chat by Comm100